3 results
Approved WMOPending
This trial will compare the effectiveness and possible adverse effects of five common wound dressing materials to treat donor sites of split skin grafts.
Approved WMORecruiting
Primary(Part I and Part II):- To determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) in the QW and/or Q3W regimens of RO7122290 in combination with cibisatamab after pretreatment with obinutuzumab- To characterize theā¦
Approved WMOCompleted
To assess PK of MPhs and MP.